Canopy Growth Corporation (CGC)
NASDAQ: CGC · Real-Time Price · USD
2.830
+0.120 (4.43%)
At close: Dec 20, 2024, 4:00 PM
2.840
+0.010 (0.35%)
After-hours: Dec 20, 2024, 7:53 PM EST
Canopy Growth Market Cap
Canopy Growth has a market cap or net worth of $296.16 million as of December 20, 2024. Its market cap has decreased by -50.55% in one year.
Market Cap
296.16M
Enterprise Value
558.88M
1-Year Change
-50.55%
Ranking
Category
Stock Price
$2.83
Market Cap Chart
Since May 24, 2018, Canopy Growth's market cap has decreased from $5.67B to $296.16M, a decrease of -94.77%. That is a compound annual growth rate of -36.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 298.20M | -29.62% |
| Dec 29, 2023 | 423.70M | -62.25% |
| Dec 30, 2022 | 1.12B | -67.34% |
| Dec 31, 2021 | 3.44B | -62.54% |
| Dec 31, 2020 | 9.17B | 26.27% |
| Dec 31, 2019 | 7.26B | 34.51% |
| Dec 31, 2018 | 5.40B | -4.72% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CVRx, Inc. | 293.83M |
| Cerus | 293.43M |
| 4D Molecular Therapeutics | 291.70M |
| Aclaris Therapeutics | 291.00M |
| Aldeyra Therapeutics | 290.60M |
| Foghorn Therapeutics | 285.75M |
| Candel Therapeutics | 284.16M |
| Procaps Group | 283.19M |